Abeona Therapeutics, Inc. Forecast, price target & analysts
Abeona Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation
Abeona Therapeutics, Inc. Classifications & Recommendation:
Abeona Therapeutics, Inc. Price Target
| Target Price | $20.40 |
| Price | $5.53 |
| Potential |
268.90%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Abeona Therapeutics, Inc. 2026 .
The average Abeona Therapeutics, Inc. target price is $20.40.
This is
268.90%
register free of charge
$28.88
422.15%
register free of charge
$14.14
155.70%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Abeona Therapeutics, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Abeona Therapeutics, Inc. stock has an average upside potential 2026 of
268.90%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 28.02 |
| 100.00% |
9 Analysts have issued a sales forecast Abeona Therapeutics, Inc. 2025 . The average Abeona Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
9 Abeona Therapeutics, Inc. Analysts have issued a net profit forecast 2025. The average Abeona Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.55 | 1.30 |
| 38.74% | 183.87% | |
| P/E | 4.26 | |
| EV/Sales | 2.77 |
9 Analysts have issued a Abeona Therapeutics, Inc. forecast for earnings per share. The average Abeona Therapeutics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Abeona Therapeutics, Inc....
Current Abeona Therapeutics, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | May 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 15 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
May 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 30 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
